BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced that its wholly owned European subsidiary, Sucampo Pharma Europe, Ltd. (SPE), has appointed David Dodds, MRPharmS, M.B.A., to the position of Commercial Director of Europe. Mr. Dodds will be responsible for establishing Sucampo’s European operations, management, business development and commercial strategies.
